News

As a part of the contract, Boehringer will offer cell line development along with high expression BI-HEX system, full process and method development and scale-up for APX005, an

Candesartan Cilexetil and Hydrochlorothiazide Tablets in 16/12.5mg, 32/12.5mg and 32/25mg strenghts, for which the company began shipment, are equivalent to AstraZeneca’s Atacand HCT medication. The fixed dose drug

The company’s scientists will use D360 to produce integrated project data views and to mine structure activity relationships by using data from their existing chemical registration and biological

Supplied from January 2013, revised formulation is indicated for acute lymphoblastic leukaemia and is free from artificial colours, artificial flavours and sugar. According to the company, the medication

Rayos, which is now available to the US physicians, is used to treat rheumatoid arthritis (RA), polymyalgia rheumatica (PMR), psoriatic arthritis (PsA), ankylosing spondylitis (AS), asthma and chronic

National Institute of Allergy and Infectious Diseases is part of the National Institutes of Health (NIH). As part of the contract, Fraunhofer will receive $1.76m for the first

Patent broadly covers RNA-based oligonucleotide therapeutics such as a RNA duplex, a microRNA mimic, a microRNA antagonist and a RNA-binding RNA steric blocker containing a UNA. The RNA

Epigenomics chief financial officer and acting chief executive officer Thomas Taapken said based on the achieved non-inferiority in CRC detection, the company believes that Epi proColon has demonstrated

The new patent entitled Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for the Treatment of Narcolepsy provides protection until December 2019. Jazz Pharmaceuticals chairman and chief executive